Net Loss

Widened from ($1.86 million) in Q3 2024 to ($5.66 million) in Q4 2024

The net loss dramatically widened despite strong financing inflows. This widening reflects increased operating and non-operating costs—such as the sharp reversal in Other Income—that outweighed improvements in financing, indicating that higher expenditures or adverse adjustments (e.g., non-cash charges) contributed to deeper losses. " "

Interest Income

Increased from $1,916 in Q3 2024 to $145,518 in Q4 2024

Interest income showed an exceptional turnaround, likely due to the dramatic increase in available cash balances generating more interest, as well as possible improvements in the interest rate environment that boosted yield on cash holdings. " "

Financing Performance

Jumped from $4.16 million in Q3 2024 to $47.12 million in Q4 2024

The surge in financing performance was driven by aggressive capital raising activities in Q4. This infusion not only provided substantial cash inflows but also enabled significant improvements in the company’s liquidity, reflecting a strong investor appetite and enhanced market confidence. " "

Balance Sheet Strength

Total assets increased from $5.03 million to $50.74 million; equity improved from a deficiency of ($2.92 million) to $41.46 million

Large financing inflows almost decupled total assets and reversed the stockholders’ equity position. These improvements indicate that despite ongoing operational challenges, a successful capital raise (as indicated by the financing performance) significantly bolstered the company’s balance sheet and liquidity, improving investor confidence. " "

Operating Cash Flow

Deteriorated from ($1.58 million) in Q3 2024 to ($2.30 million) in Q4 2024

The operating cash flow worsened due to higher outflows, suggesting increased operational spending or inefficiencies that were not offset by operating revenues. This deterioration may also reflect investments and non-cash adjustments that pushed cash usage further into the negative. " "

Other Income (Expenses)

Reversed from a positive $627,878 in Q3 2024 to a negative ($3.12 million) in Q4 2024

A dramatic reversal in Other Income—from a modest gain to a significant loss—likely resulted from unfavorable shifts in the valuation of liabilities (such as warrant or conversion feature adjustments), increased interest expense, and other non-operating items. These changes underscore the company’s exposure to market volatility and valuation re-assessments impacting overall results. " "